4.1 Article

Conference proceedings from hybrid 25th Bangkok International Symposium on HIV Medicine

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Christopher C. Butler et al.

Summary: This study aimed to determine the safety, effectiveness, and cost-effectiveness of molnupiravir in vaccinated high-risk patients in the community. The results showed that molnupiravir did not reduce hospital admissions or deaths associated with COVID-19 compared to usual care in this population.

LANCET (2023)

Article Biochemistry & Molecular Biology

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

Qian Wang et al.

Summary: The BQ and XBB subvariants of SARS-CoV-2 Omicron, with additional spike mutations, are rapidly expanding and have altered antibody evasion properties. Neutralization of BQ.1, BQ.1.1, XBB, and XBB.1 by vaccinated individuals and infected persons' sera was significantly impaired, including those boosted with a WA1/BA.5 bivalent mRNA vaccine. The titers against BQ and XBB subvariants were much lower than observed before, indicating that these subvariants pose a serious threat to current COVID-19 vaccines and render all authorized antibodies inactive.
Article Medicine, General & Internal

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

Sinead Delany-Moretlwe et al.

Summary: The study aimed to assess the safety and efficacy of injectable cabotegravir compared with daily oral tenofovir diphosphate plus emtricitabine for HIV prevention in HIV-uninfected women. The results showed that cabotegravir was superior to TDF-FTC in preventing HIV infection among women.

LANCET (2022)

Article Medicine, General & Internal

Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19

Myron J. Levin et al.

Summary: A single dose of AZD7442 showed efficacy in preventing Covid-19 without evident safety concerns. The study suggests that AZD7442 may provide potential protection for individuals who have an inadequate response to vaccination or an increased risk of exposure.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Editorial Material Immunology

Early clues regarding the pathogenesis of long-COVID

Michael J. J. Peluso et al.

Summary: Intense investigation is being carried out to understand the predictors and determinants of post-acute sequelae of SARS-CoV-2 infection (PASC), including 'long COVID'. Recent studies provide clues to the mechanisms behind this condition, aiming to identify host or virus factors that can be intervened upon to prevent or reverse PASC.

TRENDS IN IMMUNOLOGY (2022)

Article Geriatrics & Gerontology

Association of Phenotypic Aging Marker with comorbidities, frailty and inflammatory markers in people living with HIV

Win Min Han et al.

Summary: In this study, predictors of novel aging markers PhenoAge and PAA in people living with HIV were evaluated, with male sex, smoking, diabetes, hypertension, frailty, and high IL-6 levels independently associated with higher PAA. The PhenoAge marker showed better discrimination for frailty compared to chronological age alone, indicating its potential usefulness in identifying high-risk PLWH within a similar chronological age group.

BMC GERIATRICS (2022)

Article Biochemistry & Molecular Biology

Symptoms and risk factors for long COVID in non-hospitalized adults

Anuradhaa Subramanian et al.

Summary: A retrospective analysis of primary care records in the United Kingdom reveals individual symptoms associated with SARS-CoV-2 infections, which persisted for 12 weeks or more after infection, as well as risk factors associated with developing long COVID.

NATURE MEDICINE (2022)

Article Medicine, General & Internal

Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer

J. M. Palefsky et al.

Summary: Treatment for anal HSIL can significantly reduce the risk of anal cancer in persons living with HIV.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Review Medicine, General & Internal

Treatment Outcomes Among Pregnant Patients With Multidrug-Resistant Tuberculosis A Systematic Review and Meta-analysis

Kefyalew Addis Alene et al.

Summary: The management of multidrug-resistant tuberculosis (MDR-TB) during pregnancy is challenging. This study systematically synthesized treatment outcomes and adverse events among pregnant patients with MDR-TB. The results showed high treatment success rates and favorable pregnancy outcomes, providing important insights for the management of MDR-TB in pregnant patients.

JAMA NETWORK OPEN (2022)

Review Medicine, General & Internal

Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review

Kin Israel Notarte et al.

Summary: This systematic review investigates the association between COVID-19 vaccination and long-COVID symptoms. The findings suggest that vaccination is associated with reduced risks of long-COVID, with preliminary evidence showing that two doses are more effective than one dose. The impact of vaccination on people with existing long-COVID symptoms is still controversial.

ECLINICALMEDICINE (2022)

Article Public, Environmental & Occupational Health

HIV and mental health among young people in low-resource contexts in Southeast Asia: A qualitative investigation

Peter A. Newman et al.

Summary: Young people aged 15-24 years in Southeast Asia account for a quarter of HIV infections, with mental health issues also being prevalent. Research has shown intersections between HIV and mental health, leading to proposed strategies for adolescent and young key populations in Indonesia, the Philippines, Thailand, and Vietnam, including youth-friendly services, parent-adolescent communication, teacher training, and youth-led education programs.

GLOBAL PUBLIC HEALTH (2022)

Article Medicine, General & Internal

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

A. Turkova et al.

Summary: In this trial involving children and adolescents with HIV-1 infection who were starting first- or second-line treatment, dolutegravir-based ART was found to be superior to standard care.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Raphael J. Landovitz et al.

Summary: The study showed that injectable Cabotegravir was more effective in preventing HIV infection among MSM and transgender women compared to daily oral Tenofovir Disoproxil Fumarate-Emtricitabine. Strategies are needed to prevent INSTI resistance in cases of Cabotegravir PrEP failure.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance

Mohamed Fareh et al.

Summary: The study demonstrates the reprogramming of Cas13b to target and suppress SARS-CoV-2 mutations with high efficiency. The reprogrammed Cas13b shows resilience to various SARS-CoV-2 variants, making it a potential tool for antiviral drug development.

NATURE COMMUNICATIONS (2021)